APG-2449 in Patients With Advanced Solid Tumors
NCT03917043
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
165
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Cancer
Non Small Cell Lung Cancer
Esophageal Cancer
Ovarian Cancer
Malignant Pleural Mesothelioma
Interventions
DRUG:
APG-2449
Sponsor
Ascentage Pharma Group Inc.
Collaborators
[object Object]